KLAS Research | First Look Report

navify® digital solutions shine in KLAS® First Look Reports:
See how our customer benefit

Roche received high ratings from healthcare professionals for three navify digital solutions, as reported in an independent KLAS® Research survey.

The solutions include navify Tumor Board, navify POC Operations, navify Lab Operations and navify Analytics. The findings are based on 42 in-depth interviews randomly selected by KLAS from a pool of 100 Roche customers in the United States, LATAM, Europe and Asia-Pacific.

KLAS Research | First Look Report

navify® digital solutions shine in KLAS® First Look Reports:
See how our customer benefit

Roche received high ratings from healthcare professionals for three navify digital solutions, as reported in an independent KLAS® Research survey.

The solutions include navify Tumor Board, navify POC Operations, navify Lab Operations and navify Analytics. The findings are based on 42 in-depth interviews randomly selected by KLAS from a pool of 100 Roche customers in the United States, LATAM, Europe and Asia-Pacific.

KLAS’ First Look Report offers transparent and impartial insight on the real world experiences of provider organizations. Take a look at the benefits from lab managers and institutions experienced by navify digital solutions. Download reports below.

We are delighted that healthcare leader and professionals experience value with our navify digital solutions. By combining deep clinical integration, advanced data analytics, and our scientific and healthcare expertise, we are providing healthcare organization with secure, end-to-end integrated solutions that deliver evident-based, data-driven insights, to enhance operational efficiencies, and help improve patient care.

Moritz Hartmann
Head of Roche Information Solutions

navify Tumor Board report

navify Tumor Board

navify Tumor Board, a cloud-based digital solution, streamlines clinical workflows and enhances multidisciplinary collaboration during tumor board conferences, empowering more confident, personalized care decisions. Key insights from the First Look report reveals that navify Tumor Board:

  • 92.4%* overall performance
    The 2023 Best in KLAS average for this category is 80.3%. *= limited data (n=7)
  • 100% of customers interviewed were highly satisfied or satisfied
  • 86% of customers achieved tangible outcomes within 6 months
navify POC Operations report

navify POC Operations

Formally registered in most countries as cobas® infinity POC, navify POC Operations connects and monitors point-of-care devices (Roche and non-Roche) for device oversight and error management of test results. Key insights from the First Look report reveals that navify POC Operations:

  • 90.1%* overall performance
    The 2023 Best in KLAS average for this category is 80.3%. *= limited data (n=11)
  • 100% of customers interviewed were highly satisfied or satisfied
  • 100% of professionals would buy again
navify Lab Operations report

navify Lab Operations

Formally registered in most countries as cobas® infinity Lab, navify Lab Operations consolidates data from various lab instruments and systems and automates lab processes for optimal lab efficiency. Key insights from the First Look report reveals that navify Lab Operations:

  • 89.5%* overall performance score
  • The 2023 Best in KLAS average for this category is 80.3%. *= limited data (n=14)
  • 100% of customers interviewed were highly satisfied or satisfied
  • 90% of professionals said it achieved tangible outcomes
navify Analytics report

navify Analytics

navify Analytics is a cloud-based digital solution that provides actionable insights to support the improvement of laboratory and Point of Care management. Key insights from the First Look report reveal that navify Analytics:

  • 91.9%* overall performance – the 2024 Best in KLAS average for this category is 79.6%. *= limited data (n=10)
  • 100% of customers interviewed were highly satisfied or satisfied
  • 100% of professionals would buy again

About KLAS Research

KLAS is a research and insights firm on a global mission to improve healthcare. Working with thousands of healthcare professionals and clinicians, KLAS gathers data and insights on software and services to deliver timely reports and performance data that represent provider and payer voices and act as catalysts for improving vendor performance. The KLAS research team publishes reports covering the most pressing questions facing healthcare technology today, including emerging technology insights, that provide early insights on the future of healthcare technology solutions. KLAS also fosters measurement and collaboration between healthcare providers and payers and best practice adoption. Learn more at klasresearch.com.

Explore
more

navify Tumor Board: Modernizing tumor board conferences to support multidisciplinary team decisions.

Read more

cobas® infinity POC (navify POC Operations) is an integrated web based application with open connectivity that helps manage Point of Care Testing from a single location.

Read more

cobas® infinity (navify Lab Operations) laboratory solution was designed to allow you to identify, address and solve your lab’s biggest challenges, using a single, easy-to-use solution.

Read more

Find us
Roche Information Solutions
Roche Molecular Systems, Inc.
2881 Scott Blvd
Santa Clara, CA 95050

© 2024 Roche Molecular Systems, Inc.
NAVIFY is a trademark of Roche.
All other product names and trademarks are the property of their respective owners.

Not all products of this product portfolio are intended or approved for diagnostic use. This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.

Roche at HBIHIMSS APAC: Seoul, Korea
×

You will be redirected to another site. Do you want to continue?

OK